PQ 930
930. Deputy Róisín Shortall asked the Minister for Health if a decision on the reimbursement of dupilumab, a drug to treat severe atopic eczema, was reached at the December 2020 HSE drugs group meeting; and if he will make a statement on the matter. [1116/21]
Introduced
13 January 2021
Last action
13 January 2021 · Medicinal Products
Status
written
Sponsors
Shortall, Róisín.
Subjects
Discovery layer
Source updated
13 January 2021
Summary
930. Deputy Róisín Shortall asked the Minister for Health if a decision on the reimbursement of dupilumab, a drug to treat severe atopic eczema, was reached at the December 2020 HSE drugs group meeting; and if he will make a statement on the matter. [1116/21]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
13 January 2021
Medicinal Products
930. Deputy Róisín Shortall asked the Minister for Health if a decision on the reimbursement of dupilumab, a drug to treat severe atopic eczema, was reached at the December 2020 HSE drugs group meeting; and if he will make a statement on the matter. [1116/21]
Source: written
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 13 January 2021
Sponsors
- Shortall, Róisín. · Asking member
- Health · Health · Addressed to
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2021-01-13/930/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2021-01-13/pq_930
- ireland · q-2021-01-13-pq_930 · source updated 13 January 2021